Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?

To assess the ability of algorithmically assessed magnetic resonance imaging (MRI) features to predict the likelihood of upstaging to invasive cancer in newly diagnosed ductal carcinoma in situ (DCIS).

[1]  A. Hollingsworth,et al.  Multicentric and Contralateral Invasive Tumors Identified with Pre‐op MRI in Patients Newly Diagnosed with Ductal Carcinoma In Situ of the Breast , 2012, The breast journal.

[2]  R. Gelber,et al.  Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy , 2012, European Radiology.

[4]  Maciej A Mazurowski,et al.  Interobserver variability in identification of breast tumors in MRI and its implications for prognostic biomarkers and radiogenomics. , 2016, Medical physics.

[5]  D. Dabbs,et al.  Predictors of Residual Invasive Disease after Core Needle Biopsy Diagnosis of Ductal Carcinoma In Situ , 2007, The breast journal.

[6]  P. Tan,et al.  Predictors of invasion in needle core biopsies of the breast with ductal carcinoma in situ , 2010, Modern Pathology.

[7]  M. Giger,et al.  Computerized characterization of mammographic masses: analysis of spiculation. , 1994, Cancer letters.

[8]  W. Han,et al.  Sonographic lesion size of ductal carcinoma in situ as a preoperative predictor for the presence of an invasive focus , 2008, Journal of surgical oncology.

[9]  James C. Bezdek,et al.  Pattern Recognition with Fuzzy Objective Function Algorithms , 1981, Advanced Applications in Pattern Recognition.

[10]  Shou‐Tung Chen,et al.  Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components. , 2016, European journal of radiology.

[11]  J. Youk,et al.  Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer. , 2014, European journal of radiology.

[12]  Leslie M. Collins,et al.  Predicting outcomes in glioblastoma patients using computerized analysis of tumor shape: preliminary data , 2016, SPIE Medical Imaging.

[13]  Y. Cheung,et al.  MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy , 2011, Acta radiologica.

[14]  A. Luini,et al.  Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases. , 2012, Breast.

[15]  S. Ciatto,et al.  Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. , 2011, Radiology.

[16]  R. Maksimovic,et al.  Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma. , 2014, European journal of radiology.

[17]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2006, Archives of pathology & laboratory medicine.

[18]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[19]  Ying Lu,et al.  Features of Occult Invasion in Biopsy‐Proven DCIS at Breast MRI , 2013, The breast journal.

[20]  L. Esserman,et al.  The impact of preoperative magnetic resonance imaging on surgical treatment and outcomes for ductal carcinoma in situ. , 2011, Clinical breast cancer.

[21]  C. Ambrosone,et al.  Role of Preoperative Magnetic Resonance Imaging in the Surgical Management of Early-Stage Breast Cancer , 2014, Annals of Surgical Oncology.

[22]  R. Mansel,et al.  Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases , 2006, Breast Cancer Research and Treatment.

[23]  Naoko Mori,et al.  Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters , 2013, European Radiology.

[24]  N. Obuchowski,et al.  Quantitative classification of breast tumors in digitized mammograms. , 1996, Medical physics.

[25]  L. Esserman,et al.  Magnetic Resonance Imaging in Patients Diagnosed With Ductal Carcinoma-In-Situ: Value in the Diagnosis of Residual Disease, Occult Invasion, and Multicentricity , 2003, Annals of Surgical Oncology.

[26]  W. Han,et al.  Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision. , 2012, Breast.

[27]  Robert M. Haralick,et al.  Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..

[28]  B. Calhoun,et al.  Predictive markers in breast cancer: An update on ER and HER2 testing and reporting. , 2015, Seminars in diagnostic pathology.

[29]  H. Kuerer,et al.  Ductal Carcinoma In Situ: Treatment Update and Current Trends , 2015, Current Oncology Reports.

[30]  M. Bollet,et al.  Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgery. , 2014, Breast.

[31]  G. Meloni,et al.  Usefulness of magnetic resonance in patients with invasive cancer eligible for breast conservation: a comparative study. , 2014, Clinical breast cancer.

[32]  M. Mazurowski.  Radiogenomics: what it is and why it is important. , 2015, Journal of the American College of Radiology : JACR.

[33]  K. Molberg,et al.  Predictors of Invasion and Axillary Lymph Node Metastasis in Patients with a Core Biopsy Diagnosis of Ductal Carcinoma In Situ: An Analysis of 255 Cases , 2011, The breast journal.

[34]  R. Kane,et al.  Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. , 2010, Journal of the National Cancer Institute.

[35]  Daniel F Chen,et al.  Magnetic resonance imaging captures the biology of ductal carcinoma in situ. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  Maciej A Mazurowski,et al.  Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging. , 2014, Radiology.

[37]  J. Bellon,et al.  ACR Appropriateness Criteria® Conservative surgery and Radiation – Stage I and II Breast Carcinoma , 2011, The breast journal.

[38]  Nikos Dimitropoulos,et al.  Multi-scaled morphological features for the characterization of mammographic masses using statistical classification schemes , 2007, Artif. Intell. Medicine.

[39]  M. Dillon,et al.  Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only , 2006, Journal of surgical oncology.